Gao Erzhi, Yang Xi, Si Nuo, Liu Keqiang, Wang Jin-Quan, Liu Zhihong
National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
McKusick-Zhang Center for Genetic Medicine, State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Kidney Dis (Basel). 2020 Jan;6(1):43-49. doi: 10.1159/000502798. Epub 2019 Oct 22.
Alport syndrome (AS) is an inherited progressive renal disease caused by mutations in , and . Although mutation screening in the genes responsible for AS is typically performed, only a small proportion of patients receive genetic testing in China, and the functional consequences of multiple splicing variants in AS patients have not been investigated.
A family with X-linked AS was diagnosed based on family history and pathological findings from a kidney biopsy. Targeted next-generation sequencing was used to identify the causative mutation, and a minigene assay was performed to test the influence of the mutation on splicing.
A c.834+2T>G in was identified and shown to co-segregate with AS in the family. The variant is located in the canonical splicing site and is predicted to induce aberrant splicing. Minigene assay using HEK 293T cells indicated the skipping of exon 14 in -.
The novel splicing mutation identified in the current study broadened the genetic spectrum of X-linked AS and further deepened our insight of the disease's molecular mechanism.
Alport综合征(AS)是一种由[基因名称1]、[基因名称2]和[基因名称3]突变引起的遗传性进行性肾病。尽管通常会对AS相关基因进行突变筛查,但在中国只有一小部分患者接受基因检测,且尚未对AS患者中多个剪接变异体的功能后果进行研究。
根据家族病史和肾活检的病理结果诊断出一个X连锁AS家族。采用靶向二代测序来鉴定致病突变,并进行小基因检测以测试该突变对剪接的影响。
在[基因名称1]中鉴定出一个c.834+2T>G突变,并显示在家族中与AS共分离。该变异位于典型剪接位点,预计会导致异常剪接。使用HEK 293T细胞进行的小基因检测表明,[基因名称1]中第14外显子跳跃。
本研究中鉴定出的新型[基因名称1]剪接突变拓宽了X连锁AS的遗传谱,进一步加深了我们对该疾病分子机制的认识。